- Home
- TLSI vs IRWD Comparison
TLSI vs IRWD Comparison
Compare TLSI & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- IRWD
- Stock Information
- Founded
- TLSI 2010
- IRWD 1998
- Country
- TLSI United States
- IRWD United States
- Employees
- TLSI N/A
- IRWD N/A
- Industry
- TLSI Medical Specialities
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- TLSI Health Care
- IRWD Health Care
- Exchange
- TLSI Nasdaq
- IRWD Nasdaq
- Market Cap
- TLSI 244.3M
- IRWD 251.8M
- IPO Year
- TLSI N/A
- IRWD 2010
- Fundamental
- Price
- TLSI $4.55
- IRWD $2.19
- Analyst Decision
- TLSI Strong Buy
- IRWD Buy
- Analyst Count
- TLSI 4
- IRWD 5
- Target Price
- TLSI $11.13
- IRWD $4.94
- AVG Volume (30 Days)
- TLSI 128.4K
- IRWD 1.3M
- Earning Date
- TLSI 11-13-2025
- IRWD 11-04-2025
- Dividend Yield
- TLSI N/A
- IRWD N/A
- EPS Growth
- TLSI N/A
- IRWD N/A
- EPS
- TLSI N/A
- IRWD N/A
- Revenue
- TLSI $35,990,000.00
- IRWD $308,519,000.00
- Revenue This Year
- TLSI $56.71
- IRWD N/A
- Revenue Next Year
- TLSI $52.25
- IRWD N/A
- P/E Ratio
- TLSI N/A
- IRWD N/A
- Revenue Growth
- TLSI 45.50
- IRWD N/A
- 52 Week Low
- TLSI $3.42
- IRWD $0.53
- 52 Week High
- TLSI $5.88
- IRWD $5.13
- Technical
- Relative Strength Index (RSI)
- TLSI 37.64
- IRWD 70.88
- Support Level
- TLSI $4.50
- IRWD $1.76
- Resistance Level
- TLSI $4.80
- IRWD $2.10
- Average True Range (ATR)
- TLSI 0.22
- IRWD 0.16
- MACD
- TLSI -0.05
- IRWD 0.04
- Stochastic Oscillator
- TLSI 0.00
- IRWD 85.75
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.